Mark E. Burkard

6.9k total citations · 1 hit paper
124 papers, 3.6k citations indexed

About

Mark E. Burkard is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark E. Burkard has authored 124 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 50 papers in Molecular Biology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark E. Burkard's work include Microtubule and mitosis dynamics (30 papers), Cancer Genomics and Diagnostics (23 papers) and Cancer Treatment and Pharmacology (15 papers). Mark E. Burkard is often cited by papers focused on Microtubule and mitosis dynamics (30 papers), Cancer Genomics and Diagnostics (23 papers) and Cancer Treatment and Pharmacology (15 papers). Mark E. Burkard collaborates with scholars based in United States, Australia and Ireland. Mark E. Burkard's co-authors include Douglas H. Turner, Ryszard Kierzek, Susan J. Schroeder, Tianbing Xia, Christopher Cox, John SantaLucia, H. D. Van Liew, Beth A. Weaver, Lauren M. Zasadil and Gabrielle B. Rocque and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mark E. Burkard

115 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thermodynamic Parameters for an Expanded Nearest-Neighbor Model for Formation of RNA Duplexes with Watson−Crick Base Pairs

1998 920 citations Mark E. Burkard, Douglas H. Turner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Burkard United States	27	2.5k	849	633	427	394	124	3.6k
John L. Magnani United States	38	4.0k 1.6×	542 0.6×	1.1k 1.8×	295 0.7×	277 0.7×	153	6.4k
James Bean United States	21	2.3k 0.9×	244 0.3×	928 1.5×	1.0k 2.4×	643 1.6×	33	3.7k
Alex Kentsis United States	37	3.4k 1.4×	284 0.3×	799 1.3×	397 0.9×	217 0.6×	103	4.6k
Susan L. Deutscher United States	30	2.2k 0.9×	252 0.3×	594 0.9×	190 0.4×	242 0.6×	83	3.6k
Saverio Alberti Italy	37	2.4k 1.0×	394 0.5×	1.8k 2.8×	758 1.8×	532 1.4×	134	4.7k
Andrew P. Hinck United States	37	3.1k 1.2×	306 0.4×	560 0.9×	258 0.6×	230 0.6×	97	4.0k
Trond Stokke Norway	37	3.0k 1.2×	423 0.5×	1.2k 2.0×	1.0k 2.4×	680 1.7×	164	5.3k
Sharon J. Pitteri United States	39	3.1k 1.2×	259 0.3×	717 1.1×	629 1.5×	296 0.8×	103	4.9k
Vikas Kundra United States	32	1.9k 0.8×	488 0.6×	667 1.1×	426 1.0×	805 2.0×	113	4.0k
Marie Dutreix France	32	2.0k 0.8×	135 0.2×	446 0.7×	320 0.7×	603 1.5×	90	3.3k

Countries citing papers authored by Mark E. Burkard

Since Specialization

Citations

This map shows the geographic impact of Mark E. Burkard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Burkard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Burkard more than expected).

Fields of papers citing papers by Mark E. Burkard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Burkard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Burkard. The network helps show where Mark E. Burkard may publish in the future.

Co-authorship network of co-authors of Mark E. Burkard

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Burkard. A scholar is included among the top collaborators of Mark E. Burkard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Burkard. Mark E. Burkard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Emmerich, Philip B., Linda Clipson, Cheri A. Pasch, et al.. (2025). Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8+ T Cells in Breast Cancer. Cancers. 17(9). 1435–1435.

Wisinski, Kari B., Oana C. Danciu, Ami N. Shah, et al.. (2024). Abstract PO1-06-09: Phase 2 Trial with Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast CancersBig Ten Cancer Research Consortium BTCRC-BRE18-337. Cancer Research. 84(9_Supplement). PO1–6.

Zhou, Amber S., et al.. (2024). A survey of chromosomal instability measures across mechanistic models. Proceedings of the National Academy of Sciences. 121(16). e2309621121–e2309621121. 2 indexed citations

Sherer, Nathan M., et al.. (2024). One step 4× and 12× 3D-ExM enables robust super-resolution microscopy of nanoscale cellular structures. The Journal of Cell Biology. 224(2). 3 indexed citations

Tucker, John B., et al.. (2024). CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer. Cancer Research. 84(16). 2674–2689. 2 indexed citations

Deming, Dustin A., et al.. (2023). Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion–Mutated Breast Cancer. JCO Precision Oncology. 7(7). e2300174–e2300174. 2 indexed citations

Parker, William F., Alexander A. Parikh, Jashodeep Datta, et al.. (2023). Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy. Journal of Surgical Oncology. 128(2). 280–288. 4 indexed citations

Praska, Corinne, Amy K. Taylor, Noelle K. LoConte, et al.. (2023). Association of Neighborhood Disadvantage with Short- and Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology. 31(1). 488–498. 3 indexed citations

Tucker, John B., Rebeca García‐Varela, Ryan A. Denu, et al.. (2022). Misaligned Chromosomes are a Major Source of Chromosomal Instability in Breast Cancer. Cancer Research Communications. 3(1). 54–65. 19 indexed citations

10.

Senyuk, Vitalyi, Ying Jiang, Rebeca García‐Varela, et al.. (2021). Compensatory expression of NRF2-dependent antioxidant genes is required to overcome the lethal effects of Kv11.1 activation in breast cancer cells and PDOs. Redox Biology. 45. 102030–102030. 11 indexed citations

11.

Connolly, Roisín M., Fengmin Zhao, Kathy D. Miller, et al.. (2021). E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology. 39(28). 3171–3181. 76 indexed citations

12.

Denu, Ryan A., et al.. (2019). Centrosome Amplification in Cancer Disrupts Autophagy and Sensitizes to Autophagy Inhibition. Molecular Cancer Research. 18(1). 33–45. 8 indexed citations

13.

Stefely, Jonathan A., et al.. (2019). A physician-scientist preceptorship in clinical and translational research enhances training and mentorship. BMC Medical Education. 19(1). 89–89. 9 indexed citations

14.

Denu, Ryan A., Maria Shabbir, Minakshi Nihal, et al.. (2018). Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma. Molecular Cancer Research. 16(3). 517–527. 51 indexed citations

15.

Choudhary, Alka, Lauren M. Zasadil, Ryan A. Denu, et al.. (2016). Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer. Molecular Cancer Therapeutics. 15(1). 48–59. 27 indexed citations

16.

Choudhary, Alka, et al.. (2013). Interphase cytofission maintains genomic integrity of human cells after failed cytokinesis. Proceedings of the National Academy of Sciences. 110(32). 13026–13031. 22 indexed citations

17.

Burkard, Mark E., Stéphane Larochelle, Chao Zhang, et al.. (2007). Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proceedings of the National Academy of Sciences. 104(11). 4383–4388. 201 indexed citations

18.

Burkard, Mark E., Douglas H. Turner, & Ignacio Tinoco. (1999). 10 The Interactions That Shape RNA Structure. Cold Spring Harbor Monograph Archive. 37. 233–264. 9 indexed citations

19.

Burkard, Mark E., Douglas H. Turner, & Ignacio Tinoco. (1999). APPENDIX 2: Schematic Diagrams of Secondary and Tertiary Structure Elements. Cold Spring Harbor Monograph Archive. 37. 681–685. 1 indexed citations

20.

Conkin, Johnny, et al.. (1993). The oxygen window and decompression bubbles: estimates and significance.. PubMed. 64(9 Pt 1). 859–65. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact